George Fennell - 10 Nov 2026 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Reporting relationship: Executive Vice President
Issuer ticker: IDXX
Reported as of: 10 Nov 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Nov 2026, 17:00:10 UTC
Prior SEC filing: 02 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Lily J. Lu, Attorney-in-Fact for George Fennell

Filing notes and source

Key filing fact

George Fennell filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 12 Nov 2026.

Key facts

This page summarizes George Fennell's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
6 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 12 Nov 2026, 17:00.

Change

Previous filing in this sequence was filed on 02 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001521861 Primary reporting owner

FENNELL GEORGE

Relationship: Executive Vice President
Address: ONE IDEXX DRIVE, WESTBROOK
Signature: /s/ Lily J. Lu, Attorney-in-Fact for George Fennell
Signature date: 12 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IDXX transaction

Common Stock

Options Exercise

Transaction value
Shares: +706
Change %: +6.8%
Price: $141.60^*
Shares after: 11,139
Date: 10 Nov 2026
Ownership: Direct

IDXX transaction

Common Stock

Options Exercise

Transaction value
Shares: +560
Change %: +5%
Price: $178.26^*
Shares after: 11,699
Date: 10 Nov 2026
Ownership: Direct

IDXX transaction

Common Stock

Options Exercise

Transaction value
Shares: +483
Change %: +4.1%
Price: $206.94^*
Shares after: 12,182
Date: 10 Nov 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IDXX transaction Derivative

Incentive Stock Option (right-to-buy)

Options Exercise

Transaction value
Shares: -706
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 10 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 706
Exercise price: $141.60
Footnotes: F1

IDXX transaction Derivative

Incentive Stock Option (right-to-buy)

Options Exercise

Transaction value
Shares: -560
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 10 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 560
Exercise price: $178.26
Footnotes: F2

IDXX transaction Derivative

Incentive Stock Option (right-to-buy)

Options Exercise

Transaction value
Shares: -483
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 10 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 483
Exercise price: $206.94
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Grant of option to buy 706 shares of Issuer common stock that vested in one installment on February 14, 2022.

Footnote F2

Grant of option to buy 560 shares of Issuer common stock that vested in one installment on February 14, 2023.

Footnote F3

Grant of option to buy 483 shares of Issuer common stock that vests in one installment on February 14, 2024.